Taking TB Treatment Without Active TB: What Happens

No Benefit

• TB drugs only work against Mycobacterium tuberculosis bacteria. Without active infection, there is nothing for them to kill.
• You would not become resistant to other illnesses, gain any immunity, or prevent future TB in any meaningful extra way beyond standard TPT.
• Drug resistance could emerge in your gut bacteria from rifamycin exposure, reducing the effectiveness of those drugs if you truly need them in future.

Drug-by-Drug Harms Over 18 Months

• Hepatotoxicity: Elevation of liver enzymes, and in severe cases, drug-induced liver injury (DILI) or fulminant liver failure. Risk increases with older age, pre-existing liver disease, alcohol use, and malnutrition. (Fishman's Pulmonary Diseases)
• Peripheral neuropathy: Numbness, tingling, burning, or weakness in the hands and feet - caused by INH interfering with pyridoxine (vitamin B6) metabolism. Risk is higher in diabetics, elderly, malnourished, and those with HIV or kidney failure. Pyridoxine (B6) supplementation reduces but does not fully eliminate this risk. (Murray & Nadel's Textbook of Respiratory Medicine)

• Massive drug interactions: Rifampin is one of the strongest inducers of the cytochrome P450 (CYP3A4) liver enzyme system in clinical use. Over 18 months, it would reduce blood levels of a huge number of other medications - anticoagulants (warfarin), oral contraceptives (leading to unwanted pregnancy), HIV drugs, antifungals, antiseizure drugs, heart medications, and many others. (Fishman's Pulmonary Diseases)
• Orange discoloration of urine, tears, sweat, and saliva - permanent staining of contact lenses and dentures.
• Rarely: flu-like syndrome, thrombocytopenia (low platelets), and hypersensitivity reactions.
• Can cause hepatitis, particularly when combined with INH.

• Hepatotoxicity: PZA is actually the most hepatotoxic of the standard first-line drugs. Its primary metabolism is hepatic, and it should be monitored closely even in legitimate short-course therapy.
• Hyperuricemia: PZA blocks uric acid excretion by the kidneys, causing gout-like joint pain and in prolonged exposure could trigger or worsen gout. (Comprehensive Clinical Nephrology)
• Photosensitivity: Increased sun sensitivity and rash.
• Note: PZA is typically used only for the first 2 months of active TB therapy because its toxicity risk outweighs benefit beyond that point. Taking it for 18 months would be extremely hazardous to the liver.

• Optic neuritis: The most feared complication. Prolonged ethambutol use causes dose- and duration-dependent damage to the optic nerve, leading to blurring, loss of color vision (especially red-green), and potentially irreversible permanent visual impairment or blindness. (Comprehensive Clinical Nephrology)
• Patients on EMB are routinely monitored with monthly visual acuity and color vision tests precisely because of this risk.

• Ototoxicity: Irreversible hearing loss (cochlear damage).
• Vestibulotoxicity: Balance problems and vertigo.
• Nephrotoxicity: Kidney damage, especially with prolonged high doses. (Comprehensive Clinical Nephrology)

Summary Table

Why Is This Scenario Possible?

1. Stop treatment under medical supervision - do not abruptly stop without a doctor if the drugs have been running long (some rebound effects).
2. Get liver function tests (ALT, AST, bilirubin) and a visual acuity check promptly.
3. Uric acid levels if pyrazinamide was included.
4. Nerve conduction study if there is tingling or numbness in the limbs.

Disclaimer: This is educational information. If this is an active concern for you or a patient, please consult a physician or infectious disease specialist immediately.